ResMed公司完善了呼吸机生产线

在扩大呼吸机产品生产线的行动中，ResMed集团达成协议获得Saimie SA公司，股权和债务大约为109百万美元。

尤其是ResMed达成协议获得Financiere ACE SAS，这是Saime SA及其附属机构的控股公司。ResMed与Saime自从1996年就有了长期合作关系，当时ResMed从Saime集团购买了第一个法国睡眠治疗配送财产。从1987年开始，Saime已经研制开发了系列完整的家用和医院使用的呼吸机。在法国和德国该公司将其产品直接销售，在欧洲和亚洲太平洋地区则通过销售网络进行分销。

ResMed主席兼首席执行官Peter C.Farrell博士评论说：“获得Saime公司将完善我们的家用呼吸机产品生产线，并能够迅速扩大我们的市场，以及在欧洲和其它地区的销售网络。VS和Elisee系列产品是尖端产品，但是能够十分便于医生、临床工作人员和患者的使用。我们相信，这些设备将补充我们的VPAP III和AutoSet CS设备，使得我们能够为需要呼吸辅助设备的患者提供完整的选择。”

ResMed公司是生产用于睡眠呼吸障碍以及其它呼吸疾病治疗和控制的医疗设备领先制造商。
 
ResMed to Acquire Ventilator Company
 
In a move to enlarge its line of ventilation products, ResMed, Inc. (San Diego, CA, USA) has agreed to acquire Saimie SA (Savigny le Temple, France) for about U.S.$109 million in equity and debt.

Specifically, ResMed has agreed to acquire Financiere ACE SAS, the holding company for Saime SA and its affiliates. ResMed and Saime have had a long-standing relationship since 1996, when ResMed bought its first French sleep therapy distribution assets from the Saime group. Since its formation in 1987, Saime has developed a complete range of ventilators for use in the home and hospital markets. The company distributes its products directly in France and Germany and through a network of distributors in Europe and Asia-Pacific.

“The acquisition of Saime will complete our line of homecare ventilation products and immediately expand our market presence and distribution network in Europe and other regions,” commented Peter C. Farrell, Ph.D., chairman and CEO of ResMed. “The VS and Elisee range of products are sophisticated yet easy to use for physicians, clinicians, and patients. We believe these devices will complement our VPAP III and AutoSet CS devices and will allow us to provide the full range of options for patients who need ventilatory assistance.”

ResMed is a leading manufacturer of medical equipment for the treatment and management of sleep-disordered breathing and other respiratory disorders.